Powered by bioaccess®
Global Trial Accelerators™
Global Trial Accelerators™
Fast-Tracking First-in-Human Trials, Anywhere Hosted by bioaccess® CEO Julio G. Martínez-Clark and business development director and co-host Jesús E. Moreno, the Global Trial Accelerators™ podcast (formerly LATAM Medtech Leaders) delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia. What You’ll Learn: Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN. Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance. Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites. Why Listen? Actionable Playbooks: Reverse-engineer success stories from startups that enrolled cohorts 50% faster and secured Series B funding 12–18 months early. Regulatory Intel: Stay ahead of shifting guidelines in LATAM, Eastern Europe, and APAC with on-the-ground experts. Future-Proof Insights: Explore decentralized trials, AI-driven recruitment, and post-trial commercialization in $1B+ markets. “bioaccess®’s Serbia site activated in 8 weeks-9 months faster than our EU delay. This podcast is why we partnered with them.” – Digital Health Startup CEO New episodes drop weekly. Subscribe to unlock your shortcut to global trial velocity. Brought to you by bioaccess® – Turning “anywhere” into accelerated FDA/EMA submissions since 2010.
Choose your favorite podcast player
Over 30,000 LinkedIn followers!

Fast-Tracking First-in-Human Trials, Anywhere

The Global Trial Accelerators™ podcast (formerly known as LATAM Medtech Leaders) delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.

Recent

Dec. 18, 2025

Scott Stout, CEO & Co-Founder at MedVector Clinical Trials

In this episode, we welcome Scott Stout, a leader focused on transforming access to clinical trials through innovative provider engagement models. Through HCP Recruitment, Scott and the team at MedVector are redefining how clinical trial sites connect with patients by unlocking access to larger, mo…

Watch the Video
Dec. 18, 2025

Scott Stout, CEO & Co-Founder at MedVector Clinical Trials

This episode features Scott Stout , who is helping reshape clinical trial recruitment through MedVector’s innovative HCP Recruitment model. By engaging community physicians in a new way, MedVector enables access to larger and...

Listen to the Episode
Dec. 11, 2025

Matteo Talotta, Director of Clinical Solutions at Biorce

In this episode, we welcome Matteo Talotta, a professional whose global and multidisciplinary background spans banking, academia, government, start-ups, scale-ups, and multinational corporations. Having worked across Canada, Italy, the United States, Spain, and Romania, Matteo brings a unique, firs…

Watch the Video
Dec. 11, 2025

Matteo Talotta, Director of Clinical Solutions at Biorce

This episode features Matteo Talotta , a global leader with experience across banking, academia, government, and a wide range of organizations — from start-ups and scale-ups to large multinationals. After working in Canada, I...

Listen to the Episode
Dec. 4, 2025

Pendharkar Kulkarni, Co-Founder & CSO at Uvisa Health

In today’s episode, we sit down with Sonal Pendharkar Kulkarni, Ph.D., Co-founder and CSO of Uvisa Health. With expertise spanning women’s health, the microbiome, digital health, and medical device innovation, Sonal is leading groundbreaking work that aims to transform how vaginal health is underst…

Watch the Video
Dec. 4, 2025

Pendharkar Kulkarni, Co-founder & CSO at Uvisa Health

In this episode, we’re joined by Sonal Pendharkar Kulkarni, Ph.D. , Co-founder and Chief Science Officer at Uvisa Health . With a background that bridges women’s health, the microbiome, digital health innovation, and medical ...

Listen to the Episode

Recent Blog Posts

Nov. 12, 2025

Building a Winning Team: David Kraemer's Perspective on Talent Acquis…

In today's fast-paced business environment, building a high-performing team is paramount to achieving sustainable success. Nowhere is this truer than in the demanding world of private equity, where the stakes are high and the pressure to deliver exc…

Read the Blog Post
Oct. 11, 2025

Dr. Joseph Palumbo's Journey: From Psychiatry to Neurodegenerative Re…

Welcome to the blog! In this post, we'll be exploring the extraordinary career of Dr. Joseph Palumbo, a true pioneer in the fields of psychiatry, neurology, and neurodegenerative research. From his early work to his current role at BioVie, Dr. Palum…

Read the Blog Post
Oct. 4, 2025

PharmAla Biotech: Leading the Charge in GMP MDMA Production

Welcome to this blog post, a companion piece to our recent podcast episode featuring Nicholas Kadysh, CEO of PharmAla Biotech. In this episode, which you can listen to here, we delved into PharmAla Biotech's groundbreaking work in revolutionizing GM…

Read the Blog Post

About the Hosts

Julio G Martinez-Clark Profile Photo
Julio G Martinez-Clark

CEO, bioaccess®

Julio G. Martinez-Clark, CEO of bioaccess®, has spent over a decade dismantling barriers to Medtech, Biopharma, and Radiopharma innovation by positioning Latin America, Eastern Europe (the Balkans), and Australia as global leaders in clinical research. His work challenges entrenched perceptions of the region, transforms healthcare access for underserved populations, and reimagines how medical innovations reach commercialization. Through bioaccess®, Julio has created a blueprint for cost-effective, ethically rigorous clinical trials that accelerate time-to-market while elevating local communities.

Jesus E. Moreno Profile Photo
Jesus E. Moreno

Business Development Director, bioaccess®

Jesus E. Moreno is a business development director who provides efficient and reliable clinical research services in Latin America. With a passion for driving innovation in the healthcare sector, Jesus leverages his bilingual biomedical engineering background and his understanding of the unique challenges that Medtech startups face to provide valuable support and deliver accelerated clinical study results. Jesus profoundly understands the critical role that reliable and streamlined clinical research plays in the success of Medtech startups. He firmly believes that by offering cost-effective solutions without compromising quality, Medtech startups can achieve their clinical goals faster and make a meaningful impact in the healthcare industry. Jesus is passionate about supporting Medtech startups in their journey towards bringing innovative medical technologies to market. Jesus possesses the technical expertise to understand the complexities of medical devices and technologies. This knowledge enables him to identify tailored solutions that meet the specific needs of Medtech startups. Jesus has a bachelor's degree in biomedical engineering and a master's degree in electronics engineering.